AzTrials
AzTrials

Laparoscopic Entry TechniqueNCT02804529

A Comparison of Three Different Entry Points to Establish the Pneumoperitoneum

A study testing Veress needle in people with Laparoscopic Entry Technique, run by China-Japan Friendship Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The Palmer's point and periumbilical region are the common laparoscopic entry site to establish the pneumoperitoneum. In the present study, the investigators assess the safety and feasibility of Meng's point as a new laparoscopic entry site in cases to perform the gastrointestinal surgery. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Laparoscopic Entry Technique
What is being tested?
Veress needle
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteChina
Study dates
Jul 2016to Sep 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Any patient suitable for laparoscopic abdominal surgery

Who cannot join

  • previous abdominal surgeries

Trial locations and contacts

1 site in 1 country.

Fangqiang Meng, MD,CSCRS contact

861084206168

mengfq75@163.com

Chunmao Wang, MD.,PhD. contact

861084206168

bjchest@163.com

China1 site, 1 recruiting
  • China-Japan Friendship Hospital

    Beijing, Beijing Municipality, 100029

    Fanqiang Meng, MA, +8684206168, mengfq75@163.com

    Recruiting

Other trials in China

About this study

Official title: A Comparison of Three Different Puncture Points to Establish the Pneumoperitoneum in Laparoscopic Gastrointestinal Surgery: A Randomized Prospective Trial

The Palmer's point and periumbilical region are the common laparoscopic entry site to establish the pneumoperitoneum. In the present study, the investigators assess the safety and feasibility of Meng's point as a new laparoscopic entry site in cases to perform the gastrointestinal surgery.

This prospective and randomized study will compare the three entry techniques with regard to:

  • Complications related to the entry technique
  • Time taken to enter the abdomen.
  • The number of attempts taken to enter the abdomen
Read the detailed description

Patients of China-Japan Friendship Hospital that are having a laparoscopic surgery for general surgery purposes will participate in the study. Patients with previous abdominal surgeries will be excluded from the study. A patient information sheet will be provided and written consent will be obtained. Patients who give written consent will be randomized into the three arms of the trial. All patient information will be confidential and only be available to researches involved in the study. Only one attending surgeon of the General Surgery Department of China-Japan Friendship Hospital will participate in the study. 90 patients will be recruited over one year period and the data will be analysed by a statistician.

Being tested
Veress needle
Keywords
Laparoscopic entry, Meng's point, Veress needle

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Veress needleDevice

Study groups in NCT02804529
Study groupRoleWhat they receive
Meng's Point entryExperimentalMeng's entry involved a 0.2 cm horizontal or vertical incision using the Veress needle in the cross of lateral border of the left rectus abdominis and rib arch.
Receives: Device: Veress needle
Palmer's Point entryExperimentalPalmer's entry involved a 0.2 cm horizontal or vertical incision with the Veress needle in the left midclavicular line approximately 3 cm caudal to the 10th rib
Receives: Device: Veress needle
Periumbilllicus entryExperimentalPeriumbilllicus entry involved a 0.2 cm horizontal or vertical midline incision using the Veress needle in the lower or uper border of the umbilicus.
Receives: Device: Veress needle

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Complications during entry in laparoscopy

    Measured: During surgery

Secondary outcomes (1)
  1. Time to enter in the abdominal cavity

    Measured: During surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jun 2016 (estimated)
  2. Study startJul 2016
  3. Primary completionJun 2018 (estimated)
  4. Study completionSep 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02804529
Sponsor's protocol ID
ChinaJapanFH Meng001
Status last verified
Feb 2018
First submitted
15 Jun 2016
Last updated
9 Feb 2018
Results posted
No
Data monitoring committee
Yes
Individual data sharing
Yes

Publications

  • Granata M, Tsimpanakos I, Moeity F, Magos A. Are we underutilizing Palmer's point entry in gynecologic laparoscopy? Fertil Steril. 2010 Dec;94(7):2716-9. doi: 10.1016/j.fertnstert.2010.03.055. Epub 2010 May 10.

    PubMed 20452584
  • Angioli R, Terranova C, De Cicco Nardone C, Cafa EV, Damiani P, Portuesi R, Muzii L, Plotti F, Zullo MA, Panici PB. A comparison of three different entry techniques in gynecological laparoscopic surgery: a randomized prospective trial. Eur J Obstet Gynecol Reprod Biol. 2013 Dec;171(2):339-42. doi: 10.1016/j.ejogrb.2013.09.012. Epub 2013 Sep 23.

    PubMed 24103531
  • Ahmad G, Gent D, Henderson D, O'Flynn H, Phillips K, Watson A. Laparoscopic entry techniques. Cochrane Database Syst Rev. 2015 Aug 31;8:CD006583. doi: 10.1002/14651858.CD006583.pub4.

    PubMed 26329306

Questions about this trial

What is this clinical trial studying?

A study testing Veress needle in people with Laparoscopic Entry Technique, run by China-Japan Friendship Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Feb 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Fangqiang Meng, MD,CSCRS (861084206168, mengfq75@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Complications during entry in laparoscopy (time frame: During surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02804529, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Feb 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in